Patent ID: 11857581
Assignee: MICROSINTESIS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 19:
20. A method for reducing incidence and/or treating infections by Rotavirus in a mammal, the method comprising administering to said mammal an effective amount of a composition comprising one or more molecules secreted by or derived from a probiotic bacterium selected from the group consisting of Lactobacillus acidophilus La5, Lactobacillus fermentum, Lactobacillus rhamnosus, Lactobacillus helveticus, Lactobacillus plantarum, Lactobacillus reuteri, Lactococcus lactis, Streptococcus thermophilus, Bifidobacterium longum, Bifidobacterium bifidum, Bifidobacterium infantis, Bifidobacterium crudilactis, and combinations thereof, wherein the secreted molecules are peptides having from 2 to 10 amino acids.